See every side of every news story

Browser Extension

Monday, February 24, 2025

US Edition

Subscribe Login

Volodymyr Zelenskyy

German Politics

Israel-Hamas Conflict

Endovascular Today image

News from Endovascular Today

Topics Most Covered by Endovascular Today

Artificial Intelligence

Artificial Intelligence

Sources Covering Similar Topics

Interventional News

Cardiac Interventions Today

Cardiovascular News

Medical Device Network

cardiovascularbusiness.com

Interventional News

Cardiac Interventions Today

Cardiovascular News

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Pope Francis Vatican Olaf Scholz Volodymyr Zelenskyy Ukraine War

Trending in U.S.Israel-Hamas Conflict Basketball Baseball Tennis Donald Trump

Trending in U.K.Israel-Hamas Conflict Premier League Manchester City Manchester United Aston Villa

Trending Topics

Pope Francis Vatican Olaf Scholz Volodymyr Zelenskyy Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Blindspot Local

News from Endovascular Today

All of today’s top news stories from Endovascular Today. Get the full analysis behind how media bias impacts breaking news.

In total, 42 have been published by Endovascular Today which Ground News has aggregated in the past 3 months.

Endovascular Today’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

All of today’s top news stories from Endovascular Today. Get the full analysis behind how media bias impacts breaking news. In total, 42 have been published by Endovascular Today which Ground News has aggregated in the past 3 months.

Endovascular Today’s aggregated media bias check is . Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Endovascular Today’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Endovascular Today

Where is Endovascular Today located?Endovascular Today's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Breaking News Topics Related to Endovascular Today

Maryland

European Union

New York State

California, United States

United States

Similar News Topics

Cardiac Interventions Today

Interventional News

medtechdive.com

cardiovascularbusiness.com

Cardiovascular News

Top Endovascular Today News

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

Maryland · Maryland

E2 Raises Financing to Advance Treatment of Pulmonary Embolism - Cardiac Interventions Today

February 18, 2025—Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its next-generation clot removal technology platform for venous thromboembolism (VTE). According to the company, the funding round accelerates its VTE treatment program, with an initial focus on advancing solutions for pulmonary embolism (PE). E2 stated it seeks to address critical unmet needs in intervention…See the Story

Brainomix 360 System for AI Imaging in Stroke Evaluated in Multiple Studies - Endovascular Today

Artificial Intelligence · Maryland

Brainomix 360 System for AI Imaging in Stroke Evaluated in Multiple Studies - Endovascular Today

February 19, 2025—Brainomix, a developer of artificial intelligence (AI) imaging solutions based in Oxford, United Kingdom, recently announced a series of new studies conducted with academic stroke institutions that validated the impact of its Brainomix 360 system to improve stroke treatment rates for patients across networks. The studies were presented at the American Stroke Association’s International Stroke Conference 2025 (ISC) in Los Angele…See the Story

Viz.ai’s Stroke Solution Evaluated in Studies on Treatment Times and Financial Impact - Endovascular Today

Artificial Intelligence · Maryland

Viz.ai’s Stroke Solution Evaluated in Studies on Treatment Times and Financial Impact - Endovascular Today

February 19, 2025—Viz.ai, a developer of artificial intelligence (AI)–powered disease detection and intelligent care coordination technology, recently announced new clinical data supporting advancements in neurovascular care. According to the company, two studies showed positive outcomes with the real-world impact of Viz.ai solutions in clinical practice for patients with acute large vessel occlusion (LVO) strokes. The findings were presented at…See the Story

CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data - Cardiac Interventions Today

Boston, Massachusetts · Boston

CVRx Barostim Demonstrates Reduction in Health Care Use in Real-World Data - Cardiac Interventions Today

February 12, 2025—CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated with large, statistically significant reductions in health care use, including reductions in hospital visits (ie, hospitalization and emergency department visits) and length of stay after implantation. The data were presented at the recent Technology and Heart Failure Therapeutics (THT) conference in Boston, Mass…See the Story

Guerbet receives FDA Breakthrough Device designation for Lipiojoint liquid embolic - Interventional News

FDA · Maryland

Guerbet receives FDA Breakthrough Device designation for Lipiojoint liquid embolic - Interventional News

Guerbet has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Lipiojoint, the company’s transient liquid embolic agent designed to alleviate pain and the related burden of reduced mobility in patients with knee osteoarthritis (OA). This recognition highlights the potential of Lipiojoint as a minimally invasive and targeted approach for knee OA patients who have not found relief through non-su…See the Story

CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study

Maryland · Maryland

CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH).The post CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study appeared first on Medical Device Network.See the Story

Akura enrols first subject in pulmonary embolism trial of thrombectomy system

New York State · New York

Akura enrols first subject in pulmonary embolism trial of thrombectomy system

Akura Medical has enrolled the first subject in the QUADRA-PE trial, which is assessing its Katana thrombectomy system.The post Akura enrols first subject in pulmonary embolism trial of thrombectomy system appeared first on Medical Device Network.See the Story

Czechia introduces new abdominal aortic aneurysm screening programme

Czechia introduces new abdominal aortic aneurysm screening programme

100% Left coverage: 1 sources

Estimates indicate that a well-established screening programme could prevent up to 100 deaths from abdominal aortic aneurysms each year. The post Czechia introduces new abdominal aortic aneurysm screening programme appeared first on Euractiv.See the Story

AngioDynamics initiates AMBITION BTK RCT and registry to advance treatment for CLTI - Interventional News

Maryland · Maryland

AngioDynamics initiates AMBITION BTK RCT and registry to advance treatment for CLTI - Interventional News

AngioDynamics today announced the initiation of AMBITION BTK, a randomised study of the Auryon atherectomy system in the treatment of below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI). AMBITION BTK is a multicentre, randomised controlled trial (RCT) designed to evaluate the clinical outcomes of the Auryon atherectomy system in combination with standard balloon angioplasty compared to standard balloon angioplasty alone for the treatm…See the Story

Bentley’s BeGraft and BeFlared FEVAR Bridging Systems Launched in Europe - Endovascular Today

Maryland · Maryland

Bentley’s BeGraft and BeFlared FEVAR Bridging Systems Launched in Europe - Endovascular Today

January 29, 2025—Bentley InnoMed GmbH announced the launch of the BeGraft stent graft system, an on-label bridging device for fenestrated endovascular aneurysm repair (FEVAR) procedures, and the BeFlared stent graft system, a dedicated bridging stent indicated for FEVAR procedures. According to the company, the BeFlared FEVAR device features a stent crimped on a specially designed stepped balloon that will reduce the number of steps that are nee…See the Story

Amplitude Vascular Systems Secures $36M to Advance Treatment for Calcified Arterial Disease

Boston, Massachusetts · Boston

Amplitude Vascular Systems Secures $36M to Advance Treatment for Calcified Arterial Disease

What You Should Know: – Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL™ platform, announced today that it has completed a Series B round of financing of $36M. – The funding will support the U.S. peripheral commercial launch as well as U.S. coronary and carotid IDE trials for the company’s Pulse Intravascular Lithotripsy™ (PIVL™)…See the Story